Differential clinical response to alefacept in combination with methotrexate in two patients with refractory palmar psoriasis [9]

British Journal of Dermatology

Volumn 156, Issue 1, 2007, Pages 178-180

  Jacobi, A ^a   Schuler, G ^a   Hertl, M ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; METHOTREXATE;

ADULT; CASE REPORT; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; FEMALE; HAND DISEASE; HUMAN; LETTER; LYMPHOCYTE COUNT; MALE; PALMAR PSORIASIS; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

DRUG THERAPY, COMBINATION; FEMALE; HAND DERMATOSES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PSORIASIS; RECOMBINANT FUSION PROTEINS;

EID: 33845522881     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07571.x     Document Type: Letter

References (12)

1. Pettey AA, Balkrishnan R, Rapp SR et al. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol 2003; 49:271-5.
2. Myers W, Christiansen L, Gottlieb AB. Treatment of palmoplantar psoriasis with intramuscular alefacept. J Am Acad Dermatol 2005;53:127-9.
3. Ortonne JP, Prinz JC. Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis. Eur J Dermatol 2004; 14:41-5.
4. Gottlieb AB. Alefacept for psoriasis and psoriatic arthritis. Ann Rheum Dis 2005; 64:58-60.
5. Vitez L, Heese E, Wozel G. Long-term remission after 1 course of 12 weeks of alefacept therapy - a case report. Dermatology 2005; 211:165-6.
6. Schmitt J, Stoller E, Wozel G. Alefacept. Successful long-term therapy of a severe psoriasis. Hautarzt 2005; 56:360-2.
7. Thaci D, Pätzold S, Kaufmann R, Boehncke WH. Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases. Br J Dermatol 2005; 152:1048-50.
8. Sterry W, Barker J, Boehncke WH et al. Biological therapies in the systemic management of psoriasis. International Consensus Conference. Br J Dermatol 2004; 151:3-17.
9. Mrowietz U. Psoriasis therapy with biologicals. Hautarzt 2003; 54:224-9.
10. Jacobi A, Manger B, Schuler G, Hertl M. Therapeutic application of the TNF-alpha inhibitors infliximab and etanercept in inflammatory skin disorders. J Dtsch Dermatol Ges 2003; 1:259-72.
11. Jacobi A, Mahler V, Schuler G, Hertl M. Treatment of inflammatory dermatoses by tumor necrosis factor antagonists. J Eur Acad Dermatol Venereol (in press).
12. Mease PJ, Gladman DD, Keystone EC. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study. Arthritis Rheum 2006; 54:1638-45.